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Abstract
This feature article summarizes recent applications of ultrathin films of enzymes and DNA
assembled layer-by-layer (LbL). Using examples mainly from our own research, we focus on
systems developed for biocatalysis and biosensors for toxicity screening. Enzyme–poly(L-lysine)
(PLL) films, especially when stabilized by crosslinking, can be used for biocatalysis at
unprecedented high temperatures or in acidic or basic solutions on electrodes or sub-micron sized
beads. Such films have bright prospects for chiral synthesis and biofuel cells. Excellent bioactivity
and retention of enzyme structure in these films facilitates their use in detailed kinetic studies.
Biosensors and arrays employing DNA–enzyme films show great promise in predicting
genotoxicity of new drug and chemical product candidates. These devices combine metabolic
biocatalysis, reactive metabolite–DNA reactions, and DNA damage detection. Catalytic
voltammetry or electrochemiluminescence (ECL) can be used for high throughput arrays utilizing
multiple LbL “spots” of DNA, enzyme and metallopolymer. DNA–enzyme films can also be used
to produce nucleobase adduct toxicity biomarkers for detection by LC-MS. These approaches
provide valuable high throughput tools for drug and chemical product development and toxicity
prediction.
Introduction
In the early 1990s, Decher, Lvov and co-workers1-3 developed a versatile, revolutionary, yet
simple method to prepare multicomponent films of polyions and other charged materials.
Biomolecular polyions such as DNA, RNA and proteins as well as inorganic nanoparticles
can be included in these films.4-6 Construction begins by adsorbing an initial layer of
charged polyion from solution onto an oppositely charged solid surface. Loosely bound
polyions are removed by washing with water, then a second layer of polyions of the opposite
charge to the first is adsorbed. For example, if the first layer is a polycation, the second
should be a polyanion. This sequence of layer adsorption is repeated, changing the sign of
the polyion, and consequently the surface charge, at every other adsorption step.
Different components can be used in different adsorption steps, as long as polyions in
alternate steps have opposite charges. In this way layered films containing two or more
different enzymes,7 proteins and nanoparticles,5 or DNA and enzymes8 can be built up.
Moderate concentrations of the polyions in the adsorbate solutions, typically 0.5 to 3 mg
mL−1, provide excess adsorption at each step. That is, adsorption of the new polyion onto
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the oppositely charged polyion layer leads to internal charge neutralization, but reverses the
original charge on the surface.4,5 This procedure results in very stable films because as each
layer is added weakly adsorbed polyions are washed off, thus selecting only the strongest
interactions between each neighboring layer. Some polyions that have been used to make
these films are shown below. They include metal oxide nanoparticles and DNA. It is
important to realize that even though the films are constructed one layer at a time, there is
extensive intermixing between three or more neighboring layers within the film, and the
internal structure is somewhat disordered.4,5,7,9
This layer-by-layer (LbL) film assembly method has become widely popular. It has been
employed for numerous applications in many fields, as discussed in a recent review.10 A
number of interactions other than electrostatic can be utilized for film construction.11 Herein
we present a short account of our biochemically-related applications utilizing LbL films,
first to make stable films of enzymes and polyions for biocatalysis, and second to make
films of DNA, metabolic enzymes and polyions for toxicity screening.
In the mid 1990s, Yuri Lvov joined our group at the University of Connecticut as a senior
research scientist after having spent five years working in Japan. By this time, with Ariga
and Kunitake, he had already demonstrated biocatalytic films prepared by the LbL
method.12 Lvov and I specifically wished to apply the LbL method to facilitate direct
electrochemical activation of metabolic enzymes on solid electrodes. Our goal, somewhat
vague at that time, was to make future devices useful for drug development and toxicity
screening.
Film construction and enzyme voltammetry
Up until about 20 years ago, direct voltammetry of redox proteins was a difficult
proposition, and was seriously plagued by fouling of electrodes by the proteins, which often
denatured on the electrode surface.13 In the late 1980s and early 1990s, direct, reversible
voltammetry of cyt c in phosphatidylcholine films was reported.14-16 Also, Armstrong et al.
co-adsorbed proteins with aminocyclitols and polymixins on edge plane pyrolytic graphite
electrodes to give reversible voltammetry.17 Tarlov and Bowden showed that self-assembled
monolayers (SAMs) of alkylthiolcarboxylates on gold adsorb positively charged cyt c to
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give reversible voltammetry.18 These seminal reports demonstrated approaches to and the
value of protein film voltammetry, which provides direct electron transfer between redox
proteins or enzymes and electrodes in many cases. A key is to place the protein in a film or
on a surface that protects it from denaturing and fouling the electrode.
One focus of our protein film voltammetry has been the cytochrome (cyt) P450s, which are
the major Phase I metabolic enzymes catalyzing substrate oxidations in the human liver.19,20
While these enzymes evolved to produce metabolites that are easily excreted from the body,
in some cases lipophilic chemicals or drugs are bioactivated to reactive metabolites.
Bioactivation produces metabolites that can form covalent adducts with DNA bases,
proteins, and other biomolecules, and is a major source of toxicity.21-24
Cyt P450s are iron-heme proteins (P–Fe) that catalyze the transfer of oxygen atoms to
organic substrates.19,20,25 Scheme 1 depicts the currently accepted mechanistic model for
cyt P450 catalysis. Initially, the resting state of the catalytic iron heme site contains a water
molecule bound to the distal side of P–Fe(III) (1). This water freely exchanges with its
environment and does not participate in oxygen transfer reactions.25 This form of the
enzyme binds substrate RH and eliminates the distal water (2). Substrate is not bound
directly to the heme iron of P–Fe(III), but sits above it in a hydrophobic pocket within the
protein. Next, 2 is reduced by one electron to the P–Fe(II) state by a NADPH-dependent
reductase to give 3. P–Fe(II) 3 then binds dioxygen at the distal site to form a ferrous–
dioxygen or ferric superoxy complex (4).20,26-28 This complex is converted via a one
electron reduction to give 5, which is then protonated to give 6. The electron to generate
complex 5 is donated from NADPH-dependent reductase in most cases. The P–Fe(III)–OOH
(6) can also be generated by addition of hydrogen peroxide or organic peroxides in a
reversible process termed the peroxide shunt. Once 6 is formed, protonation and O–O bond
cleavage leads to elimination of water and formation of the highly reactive heme–iron(IV)–
oxo radical cation {(P•+)Fe(IV)–oxo, 7}, which transfers oxygen to bound substrate to
generate product (ROH). The product dissociates from the enzyme and the distal site is
reoccupied by an exchangeable water and is ready for another substrate turnover. Species 6
can regenerate peroxide, and 7 can reverse through a two-electron, two-proton process to
form the substrate bound 2. In addition, exposure of the ferrous form of the protein 3 to
carbon monoxide gas produces the P–Fe(II)–CO complex 9 that absorbs light at ~450 nm,
which gives these enzymes their characteristic name.
When we began our studies of cyt P450s, we felt that direct voltammetry in films on
electrodes might provide an easy route to enzyme catalyzed metabolite formation. This
could then serve as the basis of high throughput tools for investigations of metabolism, drug
development, enzyme inhibition, and toxicity. After we published the first report on enzyme
film voltammetry and catalysis with bacterial cyt P450cam using lipid films,29 we suspected
that LbL films might provide more stability and better versatility for our applications.
In 1998, Lvov’s work in our lab led to the first report of direct enzyme voltammetry in LbL
films on electrodes.30 Reversible voltammetry was obtained for films of iron heme proteins
myoglobin (Mb) and bacterial cyt P450cam, which are models for human metabolic cyt
P450s. An initial negative charge on a gold electrode was obtained by treatment with
mercaptopropane sulfonic acid. This or some other initial negative monolayer on gold was
essential to obtain reversible protein voltammetry; without it, no protein CVs were obtained.
The negatively-charged electrode was then immersed into a 1–3 mg mL−1 solution of
polycations, washed, then immersed in a solution of polyanion (Fig. 1). The polyions
adsorbed at steady state coverage in about 15–20 min, effectively reversing the charge on
the solid surface at each step. After rinsing in water, this electrode was immersed in a 1-3
mg mL−1 solution of positively charged proteins. The positive surface charge on the protein
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is achieved by dissolving it in buffer of pH below its isoelectric point. After protein is
adsorbed, the surface develops a positive charge. Adsorption of polyanion and protein are
repeated to obtain the desired number of reproducible alternating layers. Film growth was
monitored during and after each adsorption step with quartz crystal microbalance (QCM)
weighing (Fig. 2(a), (b)), spectroscopy and voltammetry.
The frequency of a QCM resonator decreases in proportion to the mass on its metal
coating.31 Drying before measurement minimizes bias from interfacial viscoelasticity
changes. In-situ QCM on MPS-coated gold/quartz resonators showed that adsorption
saturation for protein and polyion layers occurs in 15–20 min (Fig. 2(a)). For 9 MHz quartz
resonators, mass per unit area M/A (g cm−2) of the film layer is related to the QCM
frequency shift ΔF (Hz) by4
(1)
where A is the area of the gold disk on the quartz resonator in cm2. The empirical relation
between ΔF and nominal film thickness (d) for proteins and polyions is:12
(2)
QCM frequency changes after each layer of the film is adsorbed are illustrated for an LbL
assembly of Mb and DNA on an MPS–Au surface (Fig. 2(b)). Frequency of the dried film
decreased linearly and reproducibly for the adsorption steps as expected for reproducible
layer formation. From eqn (2), the total thickness of this film of 18 layers is ~95 nm. The
fraction of electroactive protein is obtained by dividing the electroactive mass of protein
obtained from integrating voltammograms by the total protein mass measured by QCM.
Enzymes were catalytically active in the DNA films, a property we utilized later for toxicity
screening. Visible absorbance spectra of the Mb/DNA films gave the characteristic Soret
band for intact Mb at 411 nm (Fig. 2(c)).
LbL films of Mb and cyt P450cam gave chemically reversible cyclic voltammograms for the
FeIII–FeII redox couple of the proteins in films on smooth gold. However, these films on
gold had only ~1.3 electroactive layers of protein. The number of electroactive layers was
increased by growing films on roughened pyrolytic graphite (PG) electrodes, which may
provide a disorder-inducing template that decreases average interprotein distance in the film
and enables more efficient “electron hopping” between redox sites. In addition, coiled
polyions adsorbed from solutions with relatively high salt concentrations provide much
more adsorbed protein in the subsequent adsorption step compared to thinner polyion layers
adsorbed from water. Films made on rough PG electrodes by adsorbing PSS from 0.5 M
NaCl and Mb from dilute pH 5.5 buffer gave up to 7 Mb electroactive layers.32 Similar
results were found for cyt P450 films as illustrated by Fig. 3.33
A detailed study of polyion–cyt P450 binding and orientation during LbL film growth was
done using QCM and AFM.34 As first layers on silver-coated QCM resonators, both cationic
PEI and anionic PSS formed polymer islands featuring globular structures of ~10 nm in
diameter as visualized by AFM. By the time the fifth layer of protein or polyion was
deposited, the film surface was relatively smooth. Cyt P450s have non-uniform charge
distributions with negative and positive sides, and could be oriented with either end up by
controlling the charge of the polyion layer onto which the protein was adsorbed.
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Biocatalysis
1 Oxidations with LbL enzyme films
Scheme 2 illustrates the general chemical–electrochemical pathway for cyt P450 and
peroxidase catalyzed oxidations of organic reactant (R) involving oxygenation30,33,35 and
carbon–carbon bond formation.36,37 Compound I represents the •PFeIV=O radical form of
the enzyme obtained by reaction with peroxides that can transfer oxygen to or accept
electrons from substrate R. For peroxidases, compound II, the non-radical PFeIV=O, can
also oxidize substrates. Scheme 1 can be driven by electrochemical catalytic reduction of
oxygen to H2O2 (on right) or by adding H2O2 (on left).
Mb serves as a good model and control for cyt P450 enzymology, since it is an iron heme
protein that catalyzes some of the same reactions, but less efficiently. For LbL films of Mb
or cyt P450cam, with oxygen in solution, two electrons are transferred to the PFeII–O2
complexes, as in the upper right hand corner of Scheme 2 to yield H2O2. Cyclic
voltammetry in aerobic buffer of films of cyt P450 or Mb, or indeed almost any iron heme
protein, shows the characteristic increase in reduction current and disappearance of the PFeII
oxidation peak (Fig. 4) due to its electrochemical catalytic reaction with oxygen.30,33
LbL films containing Mb and cyt P450cam on Au foil electrodes were used for catalysis of
styrene epoxidation, using electrolysis in solutions containing oxygen and styrene. GC-MS
was used to monitor the sole enzyme reaction product styrene oxide. The enzymes mediated
the electrochemical reduction of oxygen to hydrogen peroxide, which activates the heme
proteins to catalyze olefin oxidation (Scheme 2).
Biocatalysis with LbL films was compared with surfactant films containing the same model
enzymes for catalytic oxidation of styrene derivatives to epoxides.35 No products were
found using bare electrodes with enzymes dissolved in solution. Enzyme–polyion films on
Au electrodes coated with mercaptopropane sulfonate gave the best catalytic activities for
these oxidations. Improved performance of enzyme–polyion films is related to efficient,
reversible heme FeIII–FeII electron transfer, and better mechanical stability than the
surfactant films under hydrodynamic conditions. Furthermore, dependence of product
stereochemistry on availability of oxygen in the reaction medium for oxidation of cis-β-
methylstyrene suggested two pathways for olefin oxidation, uncovered for the first time for
cyt P450s.35 The stereoselective pathway depends on an active, high valent iron–oxygen
intermediate as in the natural enzyme system, e.g. •PFeIV=O (see Scheme 2). A second, non-
stereoselective pathway is likely to involve olefin oxidation by a peroxyl radical on an
amino-acid residue at the protein’s surface.
LbL films of the human cyt P450 1A2 were grown with PSS on higher surface area (i.e.,
than Au-foil) carbon cloth electrodes and evaluated for electrochemical- and H2O2-driven
enzyme-catalyzed oxidation of styrene to styrene oxide.38 At an applied voltage of −0.6 V
vs. SCE in an electrochemical cell, epoxidation of styrene was again mediated by catalytic
reduction of dioxygen to H2O2 (Scheme 2). This approach was compared to purely chemical
activation by adding 10 mM H2O2. For cyt P450 1A2, slightly larger turnover rates were
found for electrolytic and H2O2-driven reactions compared to conventional enzymic
reactions using cyt P450s, reductases, and NADPH. Cyt P450cam gave comparable turnover
rates in film electrolysis and enzyme solution reactions.38 Results showed that cyt P450 1A2
catalyzes styrene epoxidation faster than cyt P450cam, and suggested the usefulness of this
thin-film method for relative kinetic studies of cyt P450s.
Finally, biocatalytic properties of LbL films containing Mb and cyt P450cam were optimized
with respect to film thickness, polyion type and pH.33 Again, electrochemical and peroxide-
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driven epoxidation of styrene was the test reaction. Synthetic organic polyions such as PSS,
as opposed to SiO2 nanoparticles or DNA, supported the best catalytic and electrochemical
performance. The charge transport mechanism is likely to involve electron hopping
facilitated by extensive interlayer mixing within the films. Very thin films (ca. 12–25 nm)
gave the largest turnover rates for catalytic epoxidation, and thicker films became limited by
in-film reactant transport.33 Classical bell-shaped activity–pH profiles and turnover rates
similar to those in solution again supported LbL films as excellent tools for relative kinetic
studies of enzymes. Major advantages include greatly enhanced enzyme stability and the
tiny amount of enzyme required.
In related work on a mediated enzyme, Calvo and co-workers reported fundamental studies
of LbL films of glucose oxidase (GOx) assembled with ferrocene- or osmium polymer
mediators on electrodes. Studies of the order of layer deposition identified conditions for
efficient catalysis. GOx retained high enzyme activity while the redox polyelectrolyte acted
as a “molecular wire” enabling good electrical communication between the enzyme and the
underlying electrodes.39
2 Enhancing stability of enzyme LbL films
Layered polyion–enzyme films have storage stability up to several months at 4 °C as long as
the enzyme is stable. Under hydrodynamic conditions typically used for biocatalysis, we
found that the mechanical stability of LbL enzyme films on PG electrodes is much better
than lipid films or cast or spin cast polyion–protein films. Such observations suggested that
LbL films would be more useful than many alternatives for sensor, bioreactor and biofuel
cell applications.
While conventional LbL films are quite stable on rough PG electrodes, films grown on less
adhesive surfaces such as quartz or glass often have unacceptable stability. However, cross-
linking between proteins in Mb–PSS films promoted by 1-[3-(dimethylamino)propyl]-3-
ethylcarbodiimide (EDC) greatly improved adhesion of the films to fused silica slides for
spectroscopic studies.40 Fig. 5(a) shows Soret band VIS spectra characteristic of the PFeIII
heme group of intact Mb at 411 nm. The spectra indicate that crosslinked films on fused
silica showed minimal degradation over 60 days, while non-cross-linked LbL films
degraded much more rapidly. However, very good stability of the same uncrosslinked films
on rough PG suggests that stability is controlled here by film–solid adhesion.
When crosslinked Mb–PSS films were immersed in 0.1 M HCl, a blue shift in the Mb Soret
band was observed (Fig. 5(b)) characteristic of structural changes in the region of the heme.
Return of the acid-treated films to pH 7.5 buffer regenerated the band at 411 nm at a
somewhat smaller absorbance. This shows that the acid-induced structural change was partly
reversible.40 In contrast, Mb dissolved in 0.1 M HCl is irreversible denatured and loses the
iron heme.
UV circular dichroism (CD) spectra are excellent monitors of protein secondary structure.41
Native Mb in solution has double minima at 210 and 222 nm representing predominant
(76%) α-helical regions.42 Similar minima in crosslinked Mb film CD spectra were found at
208 and 222 nm. Taken together with the characteristic Mb Soret bands, these spectra
suggest near native, stable structure of the protein in the films in buffers between pH 2 and
11. In contrast, Mb retains native structure in solution only between pH 5 to 9. Remarkably,
little change in the CD spectrum was found after Mb films were immersed in 0.1 M HCl
solution for up to 5 min (Fig. 5(c)), suggesting that the reversible acid-induced structural
changes were mainly in the vicinity of the heme region (Fig. 5(b)).
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At pH 1, Mb in solution is fully unfolded, but Fig. 5(c) shows that it retained nearly all of its
α-helical content in the crosslinked LbL films. Both the polyion film environment and
crosslinking seem to play roles in stabilizing protein secondary structure and function at low
pH. Crosslinked Mb-polyion films on pyrolytic graphite electrodes were used in strongly
acidic solutions for the electrochemical catalytic reduction of trichloroacetic acid, hydrogen
peroxide, and oxygen.40 The catalytic reduction of trichloroacetic acid by the films was
faster in 0.1 M HCl than in the medium pH range.
Microemulsions are dynamic, stable, clear, nanostructured mixtures of oil, water, surfactant
and often a co-surfactant such as a medium-chain-length alcohol. They are useful for
biocatalysis because they can dissolve organic reactants in their oil nanophases while
keeping the enzymes in LbL films in a largely aqueous environment.43-45 Additional
stabilization was required for LbL films to be usable in microemulsions. Excellent stability
and catalytic efficiency in buffers and microemulsions at room temperature was obtained for
LbL films on electrodes by linking Mb to poly(L-lysine) (PLL) covalently bound to graphite
electrodes.43
Crosslinked films consisting of two bilayers of poly(L-lysine) (PLL) and enzymes covalently
linked to surfaces provided remarkable thermostability, enabling biocatalysis at 90 °C.37
Films were made one layer at a time, but EDC-promoted crosslinking was used at every step
of film construction (Fig. 6(a)). Soret spectra, CD and voltammetry showed that PLL films
containing soybean peroxidase (SBP), horseradish peroxidase (HRP) or Mb had intact
enzyme structures and were stable for up to 9 h at 90 °C, while the same enzymes in solution
denatured completely in <20 min. LbL films and crosslinking procedures like those
discussed here are likely to fix the enzyme in its native folded state with a much higher
energy barrier to unfolding compared to the same enzyme dissolved in solution.
Rotating disk voltammetry data for the biocatalytic reduction of t-BuOOH with peroxidase-
PLL films gave a good fit to the electrochemical Michaelis–Menten equation, and provided
rate (kcat) and substrate binding constants (Km). Relative ratios kcat/Km, a measure of
catalytic efficiency, showed that HRP–PLL films were three-fold more efficient than SBP–
PLL at 25 °C, but SBP–PLL was slightly more active at 90 °C. SBP–PLL films had eight-
fold larger kcat/Km at 90 °C compared to 25 °C.
Crosslinked HRP– and SBP–PLL films were also constructed on carboxylated 500 nm
diameter silica beads to make biocatalytic particles or biocolloids.37 Oxidation of classic
peroxidase substrate o-methoxyphenol (10) to 3,3′-dimethoxy-4,4′-biphenoquinone (12,
Scheme 3)46 by peroxidase–PLL-coated silica microbeads was studied. Reactions were
initiated by injection of t-BuOOH into a dispersion of enzyme–PLL beads and substrate.
Product absorbance at 480 nm reached a steady state at all temperatures within ~8 min, at
which point all t-BuOOH was consumed. Absorbance at steady state under these conditions
is a measure of the yield of product 12, which increased with temperature (Fig. 7).37
Compared to 25 °C, yields of product 12 increased 2-fold at 90 °C and 1.5-fold at 60 °C.
While yields for HRP and SBP films were roughly the same at 25 °C, yields were
significantly larger for SBP films at 60 and 90 °C, in line with the better inherent
thermostability of SBP. Both biocolloids gave better yields at 90 °C than 25 °C, suggesting
increasing catalytic efficiency and selectivity of the multi-step oxidation of 10 to 11 to 12
(Scheme 3) because of the increase in thermal energy. These biocolloids were reusable at 90
°C with only minor loss of activity.
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Biosensors for genotoxicity screening
1 Genotoxicity
Chemicals that humans ingest or are exposed to must be assessed for toxicity. Extensive
experience in toxicity screening and prediction has been gained in the pharmaceutical
industry. As drug costs are directly tied to candidate failures,47 it is important to predict drug
toxicity at very early stages of development.48 While many good methods have been
developed for assessing aspects of drug toxicity, we perceived an unfilled niche for simple,
inexpensive, high throughput screening sensors and arrays usable at very early stages of
drug development.49
Reactions of molecules or their enzyme-generated metabolites with DNA nucleobases can
produce covalently linked nucleobase adducts which may initiate cancer.22-24 These
nucleobase adducts most often occur on guanines and adenines in DNA, and they are good
biomarkers for cancer risk.50,51 This mechanism for DNA damage is called genotoxicity.
“Bioactivation” is the term used for generation of reactive metabolites by cyt P450s and
other metabolic enzymes. Examples of substrates giving DNA-reactive metabolites include
styrene, benzo[a]pyrene, tamoxifen, nitrosamines and napthylamines.52-56
2 Electrochemical sensors for genotoxicity screening
The use of LbL films to develop biosensors was recently reviewed.57 In this section, we
focus on our quest to develop biosensor arrays for genotoxicity screening utilizing metabolic
enzymes and DNA in LbL films (Fig. 6(b)).49,58,59 These films are 20–40 nm thick to
minimize mass transport limitations. The enzyme reaction is the first step of sensor
operation. Cyt P450 enzymes in the films are activated by small concentrations (≤1 mM) of
hydrogen peroxide in the reverse of the well-known hydrogen peroxide shunt (see Schemes
1 and 2). Several reports detailed changes in product distributions when activating cyt P450s
using peroxides.20,60,61 However, in cases examined in our laboratory to date, hydrogen
peroxide activation gives the same metabolites as natural cyt P450 activation by NADPH
and cyt P450 reductase, and is appropriate and convenient for use in these sensors. The LbL
film “nanoreactor” on the sensor synthesizes reactive metabolites in the vicinity of large
concentrations of DNA in the film. The rate of DNA damage from metabolite–nucleobase
adduct formation is a measure of relative genotoxicity, and can be detected by
voltammetric,8 electrochemiluminescent,62 or LC-MS/MS methods.63,64
Our first step in biosensor development was to evaluate methodologies to detect DNA
damage. LbL films of DNA and polycations were used with no enzymes, and incubated with
known DNA damaging agents including epoxides and methylating agents.8,65 The most
successful electrochemical detection employed square wave voltammetry (SWV) for DNA
oxidation using soluble catalyst Ru(bpy)32+ or a catalytic Ru-polyvinylpyridine polymer
[Ru(bpy)22+Cl–PVP or ClRu–PVP) within the film to provide “reagentless” sensors.65 The
signal results mainly from catalytic electrochemical oxidation of the guanines66 in DNA
(Scheme 4). Detection relies on the fact that partly unfolded and ss-DNA have more
accessible guanines (G) than ds-DNA. As DNA is damaged, it partly unfolds, making the
guanines in the damaged ds-DNA more accessible to the Ru catalysts and providing larger
signals.
Direct measurement of altered nucleobases by LC-MS from DNA–PDDA films that had
been reacted with damage agents and hydrolyzed confirmed that the sensors actually detect
DNA damage.64,67 For example, sensor ratios (peak after incubation/initial peak) showed
excellent correlations with the rate of formation of N-7-methylguanine found by LC-MS
during incubation with methyl methane sulfonate (MMS) (Fig. 8) and epoxides. These
correlations demonstrate that the slopes of sensor response vs. incubation time measure
Rusling et al. Page 8
Chem Commun (Camb). Author manuscript; available in PMC 2012 October 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
relative rates of formation of damaged nucleobases, and can be used as indicators of relative
genotoxicity. Sensor and LC-MS results also correlated well with animal genotoxicity
estimated by TDLo (lowest dose producing carcinogenicity) in mice and rats.67,68
Prototype sensors capable of genotoxicity screening of chemicals and their metabolites
combined enzyme bioactivation with detection of DNA damage, mimicking events in the
human liver. LbL films were made from cyt P450s and DNA on PG electrodes (Fig. 6(b)).8
Enzymes were activated by small amounts of H2O2 to produce metabolites that react with
ds-DNA as they diffuse out of the film. DNA damage detection employed catalytic SWV
oxidation with dissolved Ru(bpy)32+. In later versions of these electrochemical sensors,
DNA damage was detected by using an inner catalytic ClRu–PVP polymer layer.65 Again,
results confirmed that sensor response was indicative of DNA damage.
Differences in levels and distributions of cyt P450s may predispose certain individuals to
higher risks of drug and chemical toxicity.69,70 For this reason, its important to know which
enzymes make toxic metabolites from a particular substrate or drug candidate. Thus, the
next step in our work was to design arrays featuring a number of cyt P450s to facilitate such
analyses. We first demonstrated this approach in an eight-electrode array with cyt P450cam,
human cyt P450 1A2 and Mb.71 Benzo[a]pyrene (B[a]P) was chosen as a test substrate
because of its relatively complex but well understood metabolism resulting in several DNA-
reactive metabolites from cyt P450 catalyzed oxidations.72-74 DNA damage in the arrays
was detected as above by increases in SWV peak ratios using soluble Ru(bpy)32+ as catalyst.
Fig. 9 shows data from such an array expressed as sensor peak ratio vs. enzyme incubation
time.71 Initial slopes of these plots were divided by the amount of each enzyme obtained by
QCM to give relative turnover rates {(nmol enzyme)−1 cm−2 min−1} of 3.0 for cyt P450cam,
3.5 for cyt P450 1A2 and 0.9 for Mb. Cyt P450cam and cyt P450 1A2 showed three-fold
higher activity for bioactivation of B[a]P for DNA damage than the model enzyme Mb, as
expected.
2 Electrochemiluminescent (ECL) sensors for genotoxicity screening
In ECL, an electrochemically driven redox reaction provides an ion or molecule in a
photoexcited state from which light emission can be measured. For example, when
Ru(bpy)32+ is oxidized to Ru(bpy)33+, ECL can be generated by using a sacrificial reductant,
often tripropylamine or oxalate. This produces photoexcited [Ru(bpy)32+]* by a pathway
involving reaction of a radical form of the reductant with electrochemically generated
Ru(bpy)33+.75-77 Alternatively, Ru(bpy)3+ is formed by reduction of Ru(bpy)32+ by the
radical, followed by combination of RuI and RuIII complexes to give [Ru(bpy)32+]*,78
which decays to ground state by emitting 610 nm light. ECL with Ru(bpy)32+-labeled DNA
using a sacrificial reductant provides a very sensitive method to detect oligonucleotide
hybridization.79-81
In collaboration with Robert Forster at Dublin City University, we found that the polymer
[Ru(bpy)2(PVP)10]2+ (Ru–PVP, PVP = poly(vinylpyridine)) shown in Scheme 5 can be
electrochemically activated in LbL films to react with DNA and generate ECL directly.62
That is, DNA itself can act as the sacrificial reductant. We used SWV to oxidize RuII sites in
the metallopolymer to RuIII, which oxidizes DNA. ECL was measured simultaneously with
SWV (Fig. 10) by positioning an optical fiber under the Ru–PVP–DNA electrode outside
the cell (Scheme 5), and directing the light via a monochromator to a photomultiplier tube.
ECL was generated only when guanine bases were present on DNA strands in the films,
suggesting that guanine radicals initially formed by catalytic oxidation of guanines in DNA
by RuIII (eqn (6)) react with the metallopolymer to produce electronically exited RuII* sites
in the film (eqn (7), Scheme 6). Alternatively, RuI–PVP can be formed from reaction of
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RuII–PVP with G•, and can then react with RuIII–PVP to produce the excited RuII* state to
give ECL.
ECL and SWV peaks increased during incubation of Ru–PVP–DNA films with known DNA
damage agent styrene oxide.62 Control incubations in buffer containing unreactive toluene
resulted in no significant changes in ECL or SWV. We recently showed that LbL films
incorporating DNA, enzymes and Ru–PVP can be used to make simultaneous ECL/SWV
toxicity screening sensors.82
The ECL approach is well suited to instrumentally convenient, high throughput toxicity
screening arrays. Individually addressable array electronics are not required. We recently
reported a prototype ECL array with a single 2.5 cm2 pyrolytic graphite (PG) block
electrode in a cell housed in a dark box with a CCD camera for detection (Scheme 7).83 Up
to 50 small individual spots, each an LbL film containing DNA, enzyme and Ru–PVP, were
manually micropipetted onto the PG block. Upon application of 1.25 V vs. SCE, the
electrochemically oxidized Ru–PVP generates light from each spot by oxidizing guanines in
the DNA (Scheme 6). As in all catalytic DNA detection schemes, larger signals are obtained
from damaged DNA because of better accessibility of the guanines to the catalyst as the ds-
DNA unravels.8 Rates of DNA damage from metabolites produced by individual cyt P450s
were estimated simultaneously from the increase in ECL intensity with reaction time.83
ECL arrays can be configured to measure the time course of reactions catalyzed by a single
enzyme, or multiple enzyme reactions for a single substrate can be followed simultaneously.
Data obtained with the array can be re-organized and presented in any way desired by
computer software.
Fig. 11(a) shows an ECL array with 49 RuPVP–DNA–enzyme spots designed to study the
time dependence of DNA damage for the bioactivation of benzo[a]pyrene by human cyt
P450 1B1 enzyme. The array spots were exposed to 0.5 mM H2O2 and 100 μM B[a]P for
various times marked on the array image. ECL intensity increased with enzyme reaction
time as shown by increases in light intensity. Control spots exposed to B[a]P or H2O2 alone
showed little change in ECL, showing that H2O2 activates the enzymes but does not damage
DNA. Fig. 11b is an ECL ratio plot from these experiments.
Again using B[a]P as substrate, Fig. 12 illustrates results of reactions with five enzymes in
similar arrays. Relative rates of DNA damage were estimated simultaneously in ~1 min of
enzyme reaction time and 20 s of array development time. The linear signal increases
indicative of DNA damage rate are illustrated by the graph on the right of Fig. 12.
Bioactivation producing DNA damage taken as the initial slopes of these graphs was in the
order cyt P4501B1 > cyt P4501A2 > cyt P450cam > cyt P4502E1 > Mb, the same as the
order of relative metabolic activity of these enzymes towards B[a]P.83 Thus, the slope of the
initial linear increase estimates the relative activity of different enzymes to produce reactive
metabolites.83 We have also compared ECL arrays to voltammetric sensors for genotoxicity
studies of N-nitrosopyrrolidine.84 This work showed that human cyt P450 2E1 bioactivated
N-nitrosopyrrolidine for DNA damage, but Mb did not.
DNA release from LBL films
Non-analytical biomedical applications of LbL DNA films have also been reported. A very
interesting biomedical application features LbL films designed to release DNA upon
incubation under physiological conditions by Lynn and co-workers.85-88 Specifically, films
of a poly(β-amino ester) (cationic) and DNA encoded for enhanced green fluorescent
protein (EGFP) were shown to degrade during incubation in PBS buffer at 37 °C over a
period of 20 h to 4 days depending on the number of layers. Films were assembled on
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silicon substrates as well as stainless steel intravascular stents. Degradation occurs via
hydrolysis of a poly(β-amino ester) cation used in film construction. The EGFP-encoded
DNA released was taken up when exposed to COS-7 cells which expressed green
fluorescent protein over a period of 20–48 h. The hydrolyzed poly(β-amino ester) was
shown to aid in the uptake of DNA into COS-7 cells.87 Atomic force microscopy (AFM),
scanning electron microscopy (SEM), ultraviolet-visible spectrometry (UV-Vis), and
fluorescent microscopy (FMS) were used to verify film assembly and deconstruction, DNA
release, and expression of green fluorescent protein, respectively.86-88 One application was
the coating of stents with therapeutic genes that could be delivered to the necessary
biological site for gene therapy treatment.88
Shen and co-workers also developed a DNA LbL film using poly (L-lysine) (PLL) that was
capable of releasing DNA.89,90 They found that the ionic strength adjusted via concentration
of sodium chloride during layering and deconstruction was crucial to the amount of DNA
incorporated into the film and hence, released during degradation.89 As ionic strength was
increased up to 0.5 M NaCl during film construction, the amount of DNA in the film
increased then drastically decreased at 1 M NaCl.89 Decomposition of the DNA–PLL films
also increased at high salt concentrations.89 Thus, controlling the ionic strength provided
control over the amount of DNA in the film and its rate of release. Ren and co-workers also
employed α-chymotrypsin to metabolize PLL thereby facilitating the release of DNA and
degradation of the film.90 They observed near linear loss of DNA over a period of 35 h
when exposed to α-chymotrypsin by UV-Vis, AFM and FMS.90 This protease digestion
system may be a good pathway for gene delivery in vivo. DNA LbL films designed by Lynn
and co-workers85-88 and Shen and co-workers89,90 show promise for use in site-directed
gene delivery in hydrolytic biological environments.
Summary and outlook for the future
We have summarized recent biochemical applications of versatile LbL films in biocatalysis
and early toxicity screening, taking examples mainly from our own research. The ability to
combine multiple polyions and biomolecules in the same film to provide multiple, improved
or new functionalities has allowed the realization of these applications. For example,
enzyme–PLL films stabilized by crosslinking can be used for biocatalysis at unprecedented
high temperatures or in acidic or basic solutions on electrodes or on microbeads. Such films
have bright prospects for chiral synthesis and biofuel cells. Furthermore, the excellent
performance and retention of secondary structure and bioactivity of enzymes in the LbL
films facilitates detailed mechanistic studies of biocatalysis using only tiny amounts of
enzyme.
Biosensors employing DNA–enzyme LbL films show great promise in predicting
genotoxicity of drugs and environmental chemicals, and should be important future tools in
chemical product development studies. These devices combine biocatalysis, DNA reactions,
and several DNA damage detection schemes. For example, catalytic voltammetry and ECL
can be used as the basis for high throughput arrays based on LbL “spots”, with ECL being
the more convenient methodology. DNA–enzyme films on high area surfaces or microbeads
(as used for the enzymes alone) can be used to make nucleobase adducts via enzyme
bioactivation that can be detected by LC-MS. This analysis provides sensor validation by
specifically measuring rates of adduct formation that correlate with sensor response vs.
incubation time. We are currently developing LbL microbead technology with LC-MS
detection that is also complimentary to the sensor arrays since it provides detailed DNA
adduct chemical structures and formation rates. In short, the inexpensive array technologies
provide rapid non-specific evidence for genotoxicity, while the more complex, more
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expensive LC-MS methods provide an improved approach to identifying metabolite-
nucleobase adducts and measure their formation rates directly.
Genotoxicity biosensor arrays will eventually be able to simultaneously and rapidly provide
relative genotoxicity data for any collections of relevant metabolic enzymes. Preliminary
results from our laboratory have also shown that rat liver or genetically enriched cyt P450
microsomes can be used in any of the genotoxicity sensor formats discussed above. Such
devices may have great advantages for general screening in very early stages of drug
development and discovery.
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Fig. 1.
LbL methodology illustrated for enzyme films.
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Fig. 2.
QCM monitoring of growth of LbL films of DNA and myoglobin (Mb) on an Au–MPS–Mb
underlayer on a Au-quartz resonator: (a) in situ kinetics of several sequential steps of Mb–
DNA assembly, (b) linear growth for dried Mb–DNA multilayers films at pH 5. Steps 8–11
were assembled without interrupting the process for drying, and (c) visible absorbance
spectrum of (Mb-PSS)8 multilayer film on quartz showing the iron heme Soret band
characteristic of structurally intact Mb at ~410 nm. Adapted with permission from ref. 30.
Copyright 1998, American Chemical Society.
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Fig. 3.
Cyclic voltammograms at 0.3 V s−1 for (cyt P450cam–PEI)n on rough PG electrodes in
acetate buffer pH 5.5 + 100 mM NaCl purged with nitrogen. The numbers on the curves
denote the number of protein layers. Peaks did not increase beyond seven layers.
Reproduced with permission from ref, 33. Copyright 2003, Wiley-VCH.
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Fig. 4.
Cyclic voltammograms at 0.3 V s−1 in pH 5.5 buffer in a sealed cell for: (a) (cyt P450cam-
PEI)6 film with no oxygen present, (b) (cyt P450cam-PEI)6 after injection of 40 mL oxygen,
(c) PEI monolayer on PG without oxygen present, and (d) PEI monolayer after injection of
40 mL oxygen. Results confirm the catalytic reduction of oxygen by the enzyme in the film,
as in Scheme 1. Reproduced with permission from ref. 33. Copyright 2003, Wiley-VCH.
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Fig. 5.
Spectra of crosslinked (PDDA–PSS)3(Mb–PSS)4 films on fused silica: (a) UV-Vis spectra
showing influence of crosslinking on stability of films stored at 5 °C in pH 7 buffer. (b) UV-
Vis spectra of a film initially at pH 7.5, immersed for 5 min in 0.1 M HCl, then returned to
pH 7.5 buffer. (c) Circular dichroism spectra after immersion in 0.1 M HCl solution. The
spectrum is virtually identical to that obtained at pH 7 in solution of LbL films. Adapted
with permission from ref. 40. Copyright 2002 American Chemical Society.
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Fig. 6.
Idealized representations of film configurations: (a) cross-linked 2-bilayer enzyme–PLL
films on solid surfaces that can be activated for biocatalysis by electrochemistry in the
presence of oxygen, or by adding hydrogen peroxide (see Scheme 2). (b) Films used in
genotoxicity sensors. The enzyme reaction produces metabolites in close proximity to DNA.
Damage to DNA is detected by voltammetry or electrochemiluminescence, or by hydrolysis
to eject nucleobase adducts, followed by LC-MS.
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Fig. 7.
Product absorbance at 480 nm for oxidation of 10 mM o-methoxyphenol in pH 6 buffer by
HRP– and SBP–PLL films on 0.5 μm silica beads containing ~8 μM enzyme at 25, 60 and
90 °C for (a) HRP–PLL films; (b) SBP–PLL films. Reactions were begun by injecting 5 mM
t-BuOOH into stirred dispersions. Controls are absorbance for 8 μM dissolved enzyme at 90
°C. Adapted with permission from ref. 37. Copyright 2007, American Chemical Society.
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Fig. 8.
Comparisons of electrochemical toxicity sensor and LC-MS data. Peak current ratio Ip,f/Ip,i
(final/initial) for simple genotoxicity sensors consisting of (PDDA–DNA)2 films on graphite
electrode-based sensor (□), and pmol nucleobase adducts found by LC-MS (●) of
hydrolyzed DNA from similar films on carbon cloth. Both assays after incubation of the
DNA films with 2 mM MMS. Adapted with permission from ref. 65. Copyright 2005,
American Chemical Society.
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Fig. 9.
Influence of incubation time with 50 μM benzo[a]pyrene and 1 mM H2O2 on the peak
current ratios from SWV of PDDA–DNA–(enzyme–DNA)2 films in an eight-electrode
array. Control is PDDA–DNA–(Mb–DNA)2 film in 50 μM benzo[a]pyrene alone (4
replicates for Mb films, three each for cyt P450 films). Amounts of proteins in the films in
nmol cm−2 were 0.26 for Mb, 0.060 for cyt P450cam, and 0.054 for cyt P540 1A2. Adapted
with permission from ref. 69. Copyright 2005, American Chemical Society.
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Fig. 10.
Simultaneous SWV and ECL responses for (Ru–PVP–DNA)2 films on PG electrodes in pH
5.5 buffer + 50 mM NaCl after incubations at 37 °C with saturated styrene oxide. Numerical
labels are incubation times in min. Adapted with permission from ref. 60. Copyright 2003,
American Chemical Society.
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Fig. 11.
(a) CCD image of ECL array with 49 individual RuPVP–DNA–enzyme spots all containing
cyt P450 1B1. Boxes denote spots that were exposed to 0.5 mM H2O2 + 100 μM B[a]P for
the labeled times (min). Controls on bottom were exposed to B[a]P or H2O2 only for
increasing amounts of time from 1–7 min as viewed from right to left (not marked for
clarity). (b) ECL ratio plot demonstrating the increase in ECL intensity vs. time of enzyme
reaction. Controls show ECL response vs. time exposed to B[a]P only (blue squares), H2O2
only (green diamonds), and 0.5 mM H2O2 + 100 μM B[a]P + 30 μM of inhibitor αNF
(purple triangles). Adapted with permission from ref. 83. Copyright 2003, American
Chemical Society.
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Fig. 12.
ECL array results for enzyme reactions with 100 μM benzo[a]pyrene + 0.5 mM H2O2 (a)
reconstructed images for reaction times of 0, 1, 3, 5 and 7 min for cyt P450 enzymes and
myoglobin on the same array. CCD images are recolorized with the brighter spots showing
more DNA damage. (b) ECL final/initial ratios normalized for the amount of enzyme in
each spot. Adapted with permission from ref. 81. Copyright 2003, American Chemical
Society.
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Scheme 1.
The cytochrome P450 catalytic cycle (adapted from various sources20,25-28).
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Scheme 2.
General biocatalytic pathways of cyt P450s, Mb and peroxidases in LbL films initiated by
electrochemistry or peroxides (R = substrate).
Rusling et al. Page 30
Chem Commun (Camb). Author manuscript; available in PMC 2012 October 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Scheme 3.
Pathway for peroxidase catalyzed oxidation of o-methoxyl–phenol.
Rusling et al. Page 31
Chem Commun (Camb). Author manuscript; available in PMC 2012 October 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Scheme 4.
Catalytic electrochemical cycle for DNA damage detection illustrated for ClRu–PVP.
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Scheme 5.
Sensor system for simultaneous ECL and voltammetry detection. The SCE reference
electrode (a), PG working electrode (b) and Pt counter electrode (c) are located in a glass
cell with an extended cylindrical glass base. A fiber optic cable (d) is positioned on the
outside of the cell directly under the sensor surface. Ru–PVP, DNA (brown), and enzyme
(blue) layers forming the active sensor film are shown to the right. The structure of the
(RuPVP) ECL catalyst is shown at the top. For clarity, only one layer of RuPVP is shown on
the sensor, although several can be used to enhance S/N.
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Scheme 6.
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Scheme 7.
ECL arrays from toxicity screening: (a) array; (b) reference electrode; (c) counter electrode;
(d) CCD camera; (e) computer; (f) dark box housing; (g) potentiostat for voltage control.
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